1) metabolites M-Ⅲ
吡格列酮代谢物M-Ⅲ
2) pioglitazone
吡格列酮
1.
Pioglitazone Combined Insulin for Type 2 Diabetes Mellitus;
吡格列酮与胰岛素联合治疗2型糖尿病疗效观察
2.
Effects of insulin and pioglitazone on proliferation,apoptosis and NO secretion of endothelial progenitor cells;
吡格列酮和胰岛素对内皮祖细胞增殖和凋亡及分泌一氧化氮的影响
3.
Relationship between nonalcoholic fatty liver disease and levels of serum adiponectin and tumor necrosis factor-α in obese rats and pioglitazone intervention;
肥胖大鼠非酒精性脂肪肝与血清脂联素和肿瘤坏死因子α的关系及吡格列酮干预
3) carboxylic acid metabolite of clopidogrel
氧吡格雷羧酸代谢物
4) Dinoprostone/metab
地诺前列酮/代谢
5) Pioglitazone Hydrochloride
盐酸吡格列酮
1.
Research to manufacture the Pioglitazone Hydrochloride orally disintegrating tablets;
盐酸吡格列酮口腔崩解片的研制
2.
Determination of Pioglitazone Hydrochloride Tablets by HPLC;
盐酸吡格列酮片的HPLC含量测定方法
6) pioglitazone hydrochloride tablets
盐酸吡格列酮片
1.
Dissolution comparison of pioglitazone hydrochloride tablets from different producers by process analysis;
过程分析比较不同厂家盐酸吡格列酮片的溶出度
2.
Pharmacokinetics of pioglitazone hydrochloride tablets in healthy human subjects after a single dose administration;
单剂口服盐酸吡格列酮片在健康人体的药代动力学
3.
Studies on the dissoulution rate of pioglitazone hydrochloride tablets;
盐酸吡格列酮片的溶出度研究
补充资料:吡格列酮
分子式:C19H20N2O3S
分子量:356.4386
CAS号:111025-46-8
性质:暂无
制备方法:暂无
用途:治疗(Ⅱ)型糖尿病
分子量:356.4386
CAS号:111025-46-8
性质:暂无
制备方法:暂无
用途:治疗(Ⅱ)型糖尿病
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条